These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 11956956

  • 21. [Glimepiride].
    Nakamura N.
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():351-6. PubMed ID: 12387017
    [No Abstract] [Full Text] [Related]

  • 22. Genetics of type 2 diabetes mellitus and other specific types of diabetes; its role in treatment modalities.
    Kota SK, Meher LK, Jammula S, Kota SK, Modi KD.
    Diabetes Metab Syndr; 2012 Sep; 6(1):54-8. PubMed ID: 23014256
    [Abstract] [Full Text] [Related]

  • 23. Disruption of Sur2-containing K(ATP) channels enhances insulin-stimulated glucose uptake in skeletal muscle.
    Chutkow WA, Samuel V, Hansen PA, Pu J, Valdivia CR, Makielski JC, Burant CF.
    Proc Natl Acad Sci U S A; 2001 Sep 25; 98(20):11760-4. PubMed ID: 11562480
    [Abstract] [Full Text] [Related]

  • 24. Candidate gene association study of insulin signaling genes and Alzheimer's disease: evidence for SOS2, PCK1, and PPARgamma as susceptibility loci.
    Hamilton G, Proitsi P, Jehu L, Morgan A, Williams J, O'Donovan MC, Owen MJ, Powell JF, Lovestone S.
    Am J Med Genet B Neuropsychiatr Genet; 2007 Jun 05; 144B(4):508-16. PubMed ID: 17440948
    [Abstract] [Full Text] [Related]

  • 25. Effect of Ginkgo biloba extract (EGb761) on glucose metabolism-related markers in streptozotocin-damaged rat brain.
    Löffler T, Lee SK, Nöldner M, Chatterjee SS, Hoyer S, Schliebs R.
    J Neural Transm (Vienna); 2001 Jun 05; 108(12):1457-74. PubMed ID: 11810408
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Genetic variations in the pancreatic ATP-sensitive potassium channel, beta-cell dysfunction, and susceptibility to type 2 diabetes.
    Chistiakov DA, Potapov VA, Khodirev DC, Shamkhalova MS, Shestakova MV, Nosikov VV.
    Acta Diabetol; 2009 Mar 05; 46(1):43-9. PubMed ID: 18758683
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. [Sulfonylurea drugs for type 2 diabetes].
    Toyota T.
    Nihon Rinsho; 2002 Sep 05; 60 Suppl 9():339-45. PubMed ID: 12387015
    [No Abstract] [Full Text] [Related]

  • 32. Desensitization of brain insulin receptor. Effect on glucose/energy and related metabolism.
    Hoyer S, Müller D, Plaschke K.
    J Neural Transm Suppl; 1994 Sep 05; 44():259-68. PubMed ID: 7897397
    [Abstract] [Full Text] [Related]

  • 33. Effect of genetic variants in KCNJ11, ABCC8, PPARG and HNF4A loci on the susceptibility of type 2 diabetes in Chinese Han population.
    Wang F, Han XY, Ren Q, Zhang XY, Han LC, Luo YY, Zhou XH, Ji LN.
    Chin Med J (Engl); 2009 Oct 20; 122(20):2477-82. PubMed ID: 20079163
    [Abstract] [Full Text] [Related]

  • 34. Brain insulin and insulin receptors in aging and sporadic Alzheimer's disease.
    Frölich L, Blum-Degen D, Bernstein HG, Engelsberger S, Humrich J, Laufer S, Muschner D, Thalheimer A, Türk A, Hoyer S, Zöchling R, Boissl KW, Jellinger K, Riederer P.
    J Neural Transm (Vienna); 1998 Oct 20; 105(4-5):423-38. PubMed ID: 9720972
    [Abstract] [Full Text] [Related]

  • 35. Insulin signaling, glucose metabolism and mitochondria: major players in Alzheimer's disease and diabetes interrelation.
    Correia SC, Santos RX, Carvalho C, Cardoso S, Candeias E, Santos MS, Oliveira CR, Moreira PI.
    Brain Res; 2012 Mar 02; 1441():64-78. PubMed ID: 22290178
    [Abstract] [Full Text] [Related]

  • 36. Models of Alzheimer's disease: cellular and molecular aspects.
    Hoyer S.
    J Neural Transm Suppl; 1997 Mar 02; 49():11-21. PubMed ID: 9266410
    [Abstract] [Full Text] [Related]

  • 37. Risk factors for Alzheimer's disease during aging. Impacts of glucose/energy metabolism.
    Hoyer S.
    J Neural Transm Suppl; 1998 Mar 02; 54():187-94. PubMed ID: 9850927
    [Abstract] [Full Text] [Related]

  • 38. Oxidative metabolism deficiencies in brains of patients with Alzheimer's disease.
    Hoyer S.
    Acta Neurol Scand Suppl; 1996 Mar 02; 165():18-24. PubMed ID: 8740985
    [Abstract] [Full Text] [Related]

  • 39. Age as risk factor for sporadic dementia of the Alzheimer type?
    Hoyer S.
    Ann N Y Acad Sci; 1994 May 31; 719():248-56. PubMed ID: 8010597
    [Abstract] [Full Text] [Related]

  • 40. Type 3 diabetes is sporadic Alzheimer׳s disease: mini-review.
    de la Monte SM.
    Eur Neuropsychopharmacol; 2014 Dec 31; 24(12):1954-60. PubMed ID: 25088942
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.